4Front Ventures (4Front Ventures) Change In Working Capital : $9.2 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is 4Front Ventures Change In Working Capital?

4Front Ventures's change in working capital for the quarter that ended in Dec. 2023 was $2.5 Mil.

4Front Ventures's change in working capital for the fiscal year that ended in Dec. 2023 was $9.2 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

4Front Ventures Change In Working Capital Historical Data

The historical data trend for 4Front Ventures's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4Front Ventures Change In Working Capital Chart

4Front Ventures Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

-2.97

5.53

7.64

20.08

9.19

4Front Ventures Quarterly Data
	Jan19	Apr19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Working Capital	Get a 7-Day Free Trial															10.21	-3.67	7.50	2.85	2.51

4Front Ventures Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.2 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

4Front Ventures Change In Working Capital Related Terms

Thank you for viewing the detailed overview of 4Front Ventures's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

4Front Ventures (4Front Ventures) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 4Front Ventures Corp (OTCPK:FFNTF) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

FFNT:Canada

Address

5060 North 40th Street, Suite 120, Phoenix, AZ, USA, 85018

Website

https://www.4frontventures.com

4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to own dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.

Executives

Leonid Gontmakher	director, officer: Chief Executive Officer	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Nicole Frederick	officer: See Remarks	C/O 4FRONT VENTURES CORP., 7010 E. CHAUNCEY LANE STE. 235, PHOENIX AZ 85054
Kristopher Krane	director	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
David Ryan Daily	director	5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Roman Tkachenko	director	5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Karl Chowscano	other: Consultant	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Chetan Gulati	director	28 REICHERT CIRCLE, WESTPORT CT 06880
Keith Edward Adams	officer: Chief Financial Officer	108 S. WETHERLY DRIVE, UNIT 4, LOS ANGELES CA 90048
Robert E Hunt	director	C/O GROWLIFE, INC., 20301 VENTURA BLVD., SUITE 126, WOODLAND HILLS CA 91364
Amit Ramanlal Patel	director	3305 PINE AVENUE, MANHATTAN BEACH CA 90266
Kathi P Lentzsch	director	5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Andrew Thut	officer: Chief Investment Officer	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Joseph R Feltham	officer: Chief Operating Officer	5060 N. 40TH STREET, STE 120, PHOENIX AZ 85018
Eric J. Rey	director	ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Nicolle Dorsey	officer: Chief Financial Officer	C/O REAL GOODS SOLAR, INC., 110 16TH STREET, 3RD FLOOR, DENVER CO 80202